Human medicines European public assessment report (EPAR): Kimmtrak, tebentafusp, Uveal Neoplasms, Date of authorisation: 01/04/...
Kimmtrak is a medicine used to treat adults with a type of eye cancer called ‘uveal melanoma’. It is used when the uveal melanoma cannot be removed by surgery or has spread to other parts of the body. Uveal melanoma is rare, and Kimmtrak was designated an …